Phreesia, Inc. (NYSE:PHR) Shares Acquired by Sei Investments Co.

Sei Investments Co. raised its position in Phreesia, Inc. (NYSE:PHR - Free Report) by 8.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 196,815 shares of the company's stock after purchasing an additional 15,241 shares during the quarter. Sei Investments Co. owned 0.34% of Phreesia worth $4,952,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Nicholas Company Inc. purchased a new stake in shares of Phreesia in the fourth quarter worth approximately $2,452,000. State Street Corp grew its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Geode Capital Management LLC increased its stake in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock worth $28,397,000 after purchasing an additional 55,934 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Phreesia by 10.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after purchasing an additional 46,209 shares during the period. Finally, Barclays PLC lifted its position in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after purchasing an additional 43,225 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

Phreesia Stock Down 2.3 %

PHR traded down $0.57 on Friday, hitting $24.27. The company had a trading volume of 774,052 shares, compared to its average volume of 430,576. The stock has a market capitalization of $1.43 billion, a price-to-earnings ratio of -16.51 and a beta of 0.82. The stock has a fifty day moving average price of $27.16 and a 200-day moving average price of $24.22. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Analysts Set New Price Targets

Several research firms recently commented on PHR. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and lifted their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price target on shares of Phreesia in a report on Thursday, March 13th. Robert W. Baird reduced their price objective on Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a report on Wednesday, December 11th. Finally, Canaccord Genuity Group upped their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $31.33.

Insider Transactions at Phreesia

In other news, COO Evan Roberts sold 2,873 shares of the firm's stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the sale, the chief operating officer now owns 779,993 shares of the company's stock, valued at $20,755,613.73. This trade represents a 0.37 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Balaji Gandhi sold 3,195 shares of the business's stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $85,018.95. Following the transaction, the chief financial officer now owns 148,509 shares in the company, valued at approximately $3,951,824.49. This trade represents a 2.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 164,269 shares of company stock valued at $4,661,469 in the last 90 days. Insiders own 5.80% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.